McKesson Operating Income 2006-2019 | MCK

McKesson annual/quarterly operating income history and growth rate from 2006 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • McKesson operating income for the quarter ending December 31, 2019 was $0.360B, a 47.29% decline year-over-year.
  • McKesson operating income for the twelve months ending December 31, 2019 was $1.051B, a 105.68% increase year-over-year.
  • McKesson annual operating income for 2019 was $0.886B, a 16.27% increase from 2018.
  • McKesson annual operating income for 2018 was $0.762B, a 89.3% decline from 2017.
  • McKesson annual operating income for 2017 was $7.122B, a 100.9% increase from 2016.
McKesson Annual Operating Income
(Millions of US $)
2019 $886
2018 $762
2017 $7,122
2016 $3,545
2015 $2,968
2014 $2,439
2013 $2,347
2012 $2,124
2011 $1,821
2010 $2,008
2009 $1,196
2008 $1,478
2007 $1,264
2006 $1,126
2005 $-216
McKesson Quarterly Operating Income
(Millions of US $)
Q3 2019 $360
Q2 2019 $626
Q1 2019 $634
Q4 2019 $-569
Q3 2018 $683
Q2 2018 $689
Q1 2018 $83
Q4 2018 $-944
Q3 2017 $834
Q2 2017 $239
Q1 2017 $633
Q4 2017 $4,739
Q3 2016 $831
Q2 2016 $580
Q1 2016 $972
Q4 2016 $740
Q3 2015 $920
Q2 2015 $954
Q1 2015 $931
Q4 2015 $700
Q3 2014 $800
Q2 2014 $787
Q1 2014 $681
Q4 2014 $605
Q3 2013 $493
Q2 2013 $686
Q1 2013 $655
Q4 2013 $667
Q3 2012 $498
Q2 2012 $606
Q1 2012 $576
Q4 2012 $682
Q3 2011 $492
Q2 2011 $478
Q1 2011 $472
Q4 2011 $623
Q3 2010 $307
Q2 2010 $417
Q1 2010 $474
Q4 2010 $573
Q3 2009 $509
Q2 2009 $467
Q1 2009 $459
Q4 2009 $498
Q3 2008 $-54
Q2 2008 $381
Q1 2008 $371
Q4 2008 $481
Q3 2007 $282
Q2 2007 $359
Q1 2007 $356
Q4 2007 $368
Q3 2006 $318
Q2 2006 $306
Q1 2006 $272
Q4 2006 $331
Q3 2005 $308
Q2 2005 $226
Q1 2005 $261
Q4 2005 $363
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $29.730B $214.319B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.565B 22.38
Align Technology (ALGN) United States $21.670B 55.43
AmerisourceBergen (ABC) United States $19.428B 13.03
Laboratory Of America Holdings (LH) United States $18.962B 17.27
Cardinal Health (CAH) United States $17.396B 10.86
Cooper (COO) United States $17.371B 28.61
Straumann Holding AG (SAUHF) Switzerland $15.709B 0.00
West Pharmaceutical Services (WST) United States $12.917B 53.88
DENTSPLY SIRONA (XRAY) United States $12.867B 25.15
Henry Schein (HSIC) United States $10.584B 19.71
CONMED (CNMD) United States $2.976B 39.57
Merit Medical Systems (MMSI) United States $2.259B 26.39
Patterson (PDCO) United States $2.203B 16.32
STAAR Surgical (STAA) United States $1.644B 85.84
Atrion (ATRI) United States $1.268B 34.94
Antares Pharma (ATRS) United States $0.583B 357.00
Invacare (IVC) United States $0.302B 0.00
Lifevantage (LFVN) United States $0.226B 18.93
Pro-Dex (PDEX) United States $0.073B 20.14
Biolase (BIOL) United States $0.021B 0.00
Endologix (ELGX) United States $0.015B 0.00